News & Articles

Advance your biopharma research through HPLC with this first-of-its-kind application-focused resource

ELRIG’s Impact Award, supported by SelectScience, is presented to an early career professional who has made a significant impact in the drug discovery community

Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse

Explore the importance of the European Pharmacopoeia to pharma manufacturers worldwide, with exclusive insights into the recently released version

Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year

The kits have been developed based on the traditional PROGEN ELISA kits which have already earned reference standard status in gene therapy centers worldwide

AMSBIO talks about the release of its new aptamer product range to fight against COVID-19

AstraZeneca will invest in VaxEquity, an Imperial College spin-off

Its investment includes a new manufacturing facility in Europe

How scientists at Kato Pharmaceuticals have expanded from early-stage development to biopharmaceutical production of clinical drug products

Gain insights on topics ranging from top pipetting techniques to immune cell therapies, microorganism detection and more

SelectScience CEO Kerry Parker shares our 2021 Queen’s Award success with scientists and manufacturer partners around the world

The innovative predictive methods support virtual screening and compound design in the absence of 3D structure data

Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cell model

In this guest article by RayBiotech Life, learn how ELISA and pseudoviruses enable COVID-19 drug development

The CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO

Fusion Antibodies and Eurofins Discovery sign co-marketing agreement to support timely and cost-effective development of innovative products for the benefit of global healthcare.

R&D manager Yahya Nuruddeen supervises multiple research teams. Here, he explains how reviews have helped him make the right decision for their laboratories

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify esophageal cancer patients for treatment with KEYTRUDA (pembrolizumab)

Patients with underlying heart problems are more than four times as likely to die from COVID-19

Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy